• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋羽星 Alloeocomatella polycladia 的乙酸乙酯提取物抑制丙型肝炎病毒复制和病毒解旋酶。

Inhibition of hepatitis C virus replication and viral helicase by ethyl acetate extract of the marine feather star Alloeocomatella polycladia.

机构信息

Department of Microbiology, Division of Medicine, Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan.

Radioisotope Center, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.

出版信息

Mar Drugs. 2012 Apr;10(4):744-761. doi: 10.3390/md10040744. Epub 2012 Mar 28.

DOI:10.3390/md10040744
PMID:22690141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3366673/
Abstract

Hepatitis C virus (HCV) is a causative agent of acute and chronic hepatitis, leading to the development of hepatic cirrhosis and hepatocellular carcinoma. We prepared extracts from 61 marine organisms and screened them by an in vitro fluorescence assay targeting the viral helicase (NS3), which plays an important role in HCV replication, to identify effective candidates for anti-HCV agents. An ethyl acetate-soluble fraction of the feather star Alloeocomatella polycladia exhibited the strongest inhibition of NS3 helicase activity, with an IC(50) of 11.7 µg/mL. The extract of A. polycladia inhibited interaction between NS3 and RNA but not ATPase of NS3. Furthermore, the replication of the replicons derived from three HCV strains of genotype 1b in cultured cells was suppressed by the extract with an EC(50) value of 23 to 44 µg/mL, which is similar to the IC(50) value of the NS3 helicase assay. The extract did not induce interferon or inhibit cell growth. These results suggest that the unknown compound(s) included in A. polycladia can inhibit HCV replication by suppressing the helicase activity of HCV NS3. This study may present a new approach toward the development of a novel therapy for chronic hepatitis C.

摘要

丙型肝炎病毒 (HCV) 是急性和慢性肝炎的致病因子,可导致肝纤维化和肝细胞癌的发展。我们从 61 种海洋生物中制备提取物,并通过针对病毒解旋酶(NS3)的体外荧光测定法对其进行筛选,以鉴定抗 HCV 药物的有效候选物。多枝海盘车的乙酸乙酯可溶部分对 NS3 解旋酶活性的抑制作用最强,IC50 为 11.7 µg/mL。A. polycladia 的提取物抑制 NS3 与 RNA 之间的相互作用,但不抑制 NS3 的 ATP 酶活性。此外,该提取物可抑制来自三种基因型 1b 的 HCV 株的复制子在培养细胞中的复制,EC50 值为 23 至 44 µg/mL,与 NS3 解旋酶测定的 IC50 值相似。该提取物不诱导干扰素或抑制细胞生长。这些结果表明,A. polycladia 中包含的未知化合物可以通过抑制 HCV NS3 的解旋酶活性来抑制 HCV 复制。本研究可能为慢性丙型肝炎的新型治疗方法提供了新的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/79b0e6008cda/marinedrugs-10-00744-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/00562b46c974/marinedrugs-10-00744-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/fc13a851ef7f/marinedrugs-10-00744-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/2e803b097021/marinedrugs-10-00744-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/2f62ea2197dd/marinedrugs-10-00744-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/c702390db75a/marinedrugs-10-00744-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/79b0e6008cda/marinedrugs-10-00744-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/00562b46c974/marinedrugs-10-00744-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/fc13a851ef7f/marinedrugs-10-00744-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/2e803b097021/marinedrugs-10-00744-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/2f62ea2197dd/marinedrugs-10-00744-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/c702390db75a/marinedrugs-10-00744-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/3366673/79b0e6008cda/marinedrugs-10-00744-g006.jpg

相似文献

1
Inhibition of hepatitis C virus replication and viral helicase by ethyl acetate extract of the marine feather star Alloeocomatella polycladia.海洋羽星 Alloeocomatella polycladia 的乙酸乙酯提取物抑制丙型肝炎病毒复制和病毒解旋酶。
Mar Drugs. 2012 Apr;10(4):744-761. doi: 10.3390/md10040744. Epub 2012 Mar 28.
2
Four Aromatic Sulfates with an Inhibitory Effect against HCV NS3 Helicase from the Crinoid Alloeocomatella polycladia.四种具有抑制海百合Alloeocomatella polycladia丙型肝炎病毒NS3解旋酶作用的芳香硫酸酯。
Mar Drugs. 2017 Apr 11;15(4):117. doi: 10.3390/md15040117.
3
Psammaplin A inhibits hepatitis C virus NS3 helicase.沙巴林 A 抑制丙型肝炎病毒 NS3 解旋酶。
J Nat Med. 2013 Oct;67(4):765-72. doi: 10.1007/s11418-013-0742-7. Epub 2013 Jan 29.
4
Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp.海洋海绵 Amphimedon sp. 的乙酸乙酯提取物对丙型肝炎病毒 NS3 的蛋白酶和螺旋酶活性的双重抑制作用
PLoS One. 2012;7(11):e48685. doi: 10.1371/journal.pone.0048685. Epub 2012 Nov 7.
5
Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase.鉴定羟基蒽醌为丙型肝炎病毒NS3解旋酶的新型抑制剂
Int J Mol Sci. 2015 Aug 7;16(8):18439-53. doi: 10.3390/ijms160818439.
6
Cholesterol sulfate as a potential inhibitor of hepatitis C virus NS3 helicase.胆固醇硫酸酯作为丙型肝炎病毒 NS3 解旋酶的潜在抑制剂。
J Enzyme Inhib Med Chem. 2014 Apr;29(2):223-9. doi: 10.3109/14756366.2013.766607. Epub 2013 Feb 25.
7
Fluoroquinolones inhibit HCV by targeting its helicase.氟喹诺酮类药物通过作用于丙型肝炎病毒(HCV)的解旋酶来抑制该病毒。
Antivir Ther. 2012;17(3):467-76. doi: 10.3851/IMP1937. Epub 2011 Oct 25.
8
NS3 Peptide, a novel potent hepatitis C virus NS3 helicase inhibitor: its mechanism of action and antiviral activity in the replicon system.NS3肽,一种新型强效丙型肝炎病毒NS3解旋酶抑制剂:其在复制子系统中的作用机制和抗病毒活性
Antimicrob Agents Chemother. 2008 Feb;52(2):393-401. doi: 10.1128/AAC.00961-07. Epub 2007 Nov 26.
9
[Preliminary screening of activity fraction of Alchornea trewioides suppresses expression of subgenomic hepatitis C virus RNA in vitro].[红背山麻杆活性部位体外抑制丙型肝炎病毒亚基因组RNA表达的初步筛选]
Zhong Yao Cai. 2013 Jun;36(6):880-3.
10
Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase.鉴定一种白藜芦醇四聚体作为丙型肝炎病毒解旋酶的有效抑制剂。
Br J Pharmacol. 2016 Jan;173(1):191-211. doi: 10.1111/bph.13358. Epub 2015 Nov 25.

引用本文的文献

1
Antiviral Activity Exerted by Natural Products against Human Viruses.天然产物对人类病毒的抗病毒活性。
Viruses. 2021 May 4;13(5):828. doi: 10.3390/v13050828.
2
Identification and Analysis of Novel Inhibitors against NS3 Helicase and NS5B RNA-Dependent RNA Polymerase from Hepatitis C Virus 1b (Con1).丙型肝炎病毒1b型(Con1)NS3解旋酶和NS5B RNA依赖性RNA聚合酶新型抑制剂的鉴定与分析
Front Microbiol. 2017 Nov 2;8:2153. doi: 10.3389/fmicb.2017.02153. eCollection 2017.
3
Marine Pharmacology in 2012-2013: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

本文引用的文献

1
Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus.替拉瑞韦的发现与研制:用于治疗基因 1 型慢性丙型肝炎病毒的 NS3-4A 蛋白酶抑制剂。
Nat Biotechnol. 2011 Nov 8;29(11):993-1003. doi: 10.1038/nbt.2020.
2
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.绿茶多酚表没食子儿茶素没食子酸酯抑制丙型肝炎病毒进入。
Hepatology. 2011 Dec;54(6):1947-55. doi: 10.1002/hep.24610.
3
Direct-acting antiviral medications for chronic hepatitis C virus infection.
2012-2013 年海洋药理学研究进展:具有抗菌、抗糖尿病、抗真菌、抗炎、抗原生动物、抗结核和抗病毒活性的海洋化合物;影响免疫系统和神经系统及其他作用机制的海洋化合物。
Mar Drugs. 2017 Aug 29;15(9):273. doi: 10.3390/md15090273.
4
Four Aromatic Sulfates with an Inhibitory Effect against HCV NS3 Helicase from the Crinoid Alloeocomatella polycladia.四种具有抑制海百合Alloeocomatella polycladia丙型肝炎病毒NS3解旋酶作用的芳香硫酸酯。
Mar Drugs. 2017 Apr 11;15(4):117. doi: 10.3390/md15040117.
5
Cloning and expression of NS3 helicase fragment of hepatitis C virus and the study of its immunoreactivity in HCV infected patients.丙型肝炎病毒 NS3 解旋酶片段的克隆与表达及其在丙型肝炎病毒感染者中免疫反应性的研究。
Iran J Basic Med Sci. 2015 Feb;18(2):159-63.
6
Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus.咖啡酸苯乙酯衍生物对丙型肝炎病毒复制的抑制作用
PLoS One. 2013 Dec 17;8(12):e82299. doi: 10.1371/journal.pone.0082299. eCollection 2013.
7
Hepatitis C virus NS3 inhibitors: current and future perspectives.丙型肝炎病毒 NS3 抑制剂:现状和未来展望。
Biomed Res Int. 2013;2013:467869. doi: 10.1155/2013/467869. Epub 2013 Oct 27.
8
Psammaplin A inhibits hepatitis C virus NS3 helicase.沙巴林 A 抑制丙型肝炎病毒 NS3 解旋酶。
J Nat Med. 2013 Oct;67(4):765-72. doi: 10.1007/s11418-013-0742-7. Epub 2013 Jan 29.
9
Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp.海洋海绵 Amphimedon sp. 的乙酸乙酯提取物对丙型肝炎病毒 NS3 的蛋白酶和螺旋酶活性的双重抑制作用
PLoS One. 2012;7(11):e48685. doi: 10.1371/journal.pone.0048685. Epub 2012 Nov 7.
用于慢性丙型肝炎病毒感染的直接作用抗病毒药物。
Gastroenterol Hepatol (N Y). 2011 Mar;7(3):154-62.
4
A new standard of care for the treatment of chronic HCV infection.慢性 HCV 感染治疗的新标准。
Nat Rev Gastroenterol Hepatol. 2011 May;8(5):257-64. doi: 10.1038/nrgastro.2011.49. Epub 2011 Apr 5.
5
New direct-acting antivirals' combination for the treatment of chronic hepatitis C.新型直接作用抗病毒药物联合治疗慢性丙型肝炎。
Liver Int. 2011 Jan;31 Suppl 1:68-77. doi: 10.1111/j.1478-3231.2010.02411.x.
6
Multiple effects of silymarin on the hepatitis C virus lifecycle.水飞蓟素对丙型肝炎病毒生命周期的多种影响。
Hepatology. 2010 Jun;51(6):1912-21. doi: 10.1002/hep.23587.
7
Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy.综述文章:针对丙型肝炎的特异性抗病毒治疗 - 治疗新时代。
Aliment Pharmacol Ther. 2010 Jul;32(1):14-28. doi: 10.1111/j.1365-2036.2010.04317.x. Epub 2010 Mar 31.
8
The odyssey of marine pharmaceuticals: a current pipeline perspective.海洋药物的探索历程:当前的管线视角。
Trends Pharmacol Sci. 2010 Jun;31(6):255-65. doi: 10.1016/j.tips.2010.02.005. Epub 2010 Apr 2.
9
Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C.解旋酶抑制剂作为丙型肝炎的特异性靶向抗病毒疗法。
Future Virol. 2009 May 1;4(3):277-293. doi: 10.2217/fvl.09.7.
10
Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor.对称苯并咪唑基苯甲酰胺解旋酶抑制剂的作用机制和特异性。
Biochemistry. 2010 Mar 9;49(9):1822-32. doi: 10.1021/bi901974a.